SOD2 and pulmonary hypertension: Infusion of recombinant human ACE2 (rhACE2) in patients with pulmonary hypertension is associated with increased plasma levels of superoxide dismutase 2 (SOD2) and reduced oxidative stress [50] (Table 1).